Faze Medicines was a Cambridge, Massachusetts biotechnology company founded in 2020 that harnessed biomolecular condensates to develop medical breakthroughs
Faze Medicines was a Cambridge, Massachusetts biotechnology company founded in 2020 that harnessed biomolecular condensates to develop medical breakthroughs. It raised $81 million and ceased operations in November 2022.